This is a very lose base that I'll judge how much ACL seeks to raise for the Onc IPO.
Two years company running costs ~16 million
Two Ph2 trials (pro rata costs as phase 3 with ~80 ppl) ~10 million
Remainder of Phase 3 costs ~20 million
Listing fees/costs ~1 million
- Forums
- ASX - By Stock
- TSN
- its all looking positive
its all looking positive, page-26
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online